Living donor liver transplantation using grafts with hepatic cysts

Seisuke Sakamoto, Shunsuke Nosaka, Takanobu Shigeta, Hajime Uchida, Ikumi Hamano, Chiaki Karaki, Hiroyuki Kanazawa, Akinari Fukuda, Atsuko Nakazawa, Mureo Kasahara – 7 September 2012 – Cystic lesions in the liver are often found through the evaluation of liver donors. Multiple cysts are worrisome, and donor candidates with multiple cysts may be unacceptable as liver donors, especially when their recipients have fibrocystic disease (FCD), which is an inherited disorder. This study reviewed 183 cases of living donor liver transplantation.

Roles of hepatocyte and myeloid CXC chemokine receptor‐2 in liver recovery and regeneration after ischemia/reperfusion in mice

Heather L. Van Sweringen, Nozomu Sakai, Ralph C. Quillin, Jeff Bailey, Rebecca Schuster, John Blanchard, Holly Goetzman, Charles C. Caldwell, Michael J. Edwards, Alex B. Lentsch – 7 September 2012 – Previous studies have demonstrated the significance of signaling through the CXC chemokine receptor‐2 (CXCR2) receptor in the process of recovery and regeneration of functional liver mass after hepatic ischemia/reperfusion (I/R). CXCR2 is constitutively expressed on both neutrophils and hepatocytes; however, the cell‐specific roles of this receptor are unknown.

Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease

Mercedes Vazquez‐Chantada, Aintzane Gonzalez‐Lahera, Ibon Martinez‐Arranz, Carmelo Garcia‐Monzon, Manuela M. Regueiro, Juan L. Garcia‐Rodriguez, Karin A. Schlangen, Iñaki Mendibil, Naiara Rodriguez‐Ezpeleta, Juan J. Lozano, Karina Banasik, Johanne M. Justesen, Torben Joergensen, Daniel R. Witte, Torsten Lauritzen, Torben Hansen, Oluf Pedersen, Nicolas Veyrie, Karine Clement, Joan Tordjman, Albert Tran, Yannik Le Marchand‐Brustel, Xabier Buque, Patricia Aspichueta, Jose J. Echevarria‐Uraga, Antonio Martin‐Duce, Joan Caballeria, Philippe Gual, Azucena Castro, Jose M. Mato, Maria L.

Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype

Shadi Abu‐Hayyeh, Georgia Papacleovoulou, Anita Lövgren‐Sandblom, Mehreen Tahir, Olayiwola Oduwole, Nurul Akmal Jamaludin, Sabiha Ravat, Vanya Nikolova, Jenny Chambers, Clare Selden, Myrddin Rees, Hanns‐Ulrich Marschall, Malcolm G. Parker, Catherine Williamson – 7 September 2012 – Intrahepatic cholestasis of pregnancy (ICP) is the most prevalent pregnancy‐specific liver disease and is associated with an increased risk of adverse fetal outcomes, including preterm labor and intrauterine death.

Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate

George A. Diaz, Lauren S. Krivitzky, Masoud Mokhtarani, William Rhead, James Bartley, Annette Feigenbaum, Nicola Longo, William Berquist, Susan A. Berry, Renata Gallagher, Uta Lichter‐Konecki, Dennis Bartholomew, Cary O. Harding, Stephen Cederbaum, Shawn E. McCandless, Wendy Smith, Gerald Vockley, Stephen A. Bart, Mark S. Korson, David Kronn, Roberto Zori, J. Lawrence Merritt, Sandesh C.S. Nagamani, Joseph Mauney, Cynthia LeMons, Klara Dickinson, Tristen L. Moors, Dion F. Coakley, Bruce F.

Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate

George A. Diaz, Lauren S. Krivitzky, Masoud Mokhtarani, William Rhead, James Bartley, Annette Feigenbaum, Nicola Longo, William Berquist, Susan A. Berry, Renata Gallagher, Uta Lichter‐Konecki, Dennis Bartholomew, Cary O. Harding, Stephen Cederbaum, Shawn E. McCandless, Wendy Smith, Gerald Vockley, Stephen A. Bart, Mark S. Korson, David Kronn, Roberto Zori, J. Lawrence Merritt, Sandesh C.S. Nagamani, Joseph Mauney, Cynthia LeMons, Klara Dickinson, Tristen L. Moors, Dion F. Coakley, Bruce F.

Wilson's disease: Changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease

Valentina Medici, Noreene M. Shibata, Kusum K. Kharbanda, Janine M. LaSalle, Rima Woods, Sarah Liu, Jesse A. Engelberg, Sridevi Devaraj, Natalie J. Török, Joy X. Jiang, Peter J. Havel, Bo Lönnerdal, Kyoungmi Kim, Charles H. Halsted – 4 September 2012 – Hepatic methionine metabolism may play an essential role in regulating methylation status and liver injury in Wilson's disease (WD) through the inhibition of S‐adenosylhomocysteine hydrolase (SAHH) by copper (Cu) and the consequent accumulation of S‐adenosylhomocysteine (SAH).

Beta‐catenin–NF‐κB interactions in murine hepatocytes: A complex to die for

Kari Nejak‐Bowen, Alexander Kikuchi, Satdarshan P.S. Monga – 3 September 2012 – Wnt/β‐catenin signaling plays an important role in hepatic homeostasis, especially in liver development, regeneration, and cancer, and loss of β‐catenin signaling is often associated with increased apoptosis. To elucidate how β‐catenin may be regulating hepatocyte survival, we investigated the susceptibility of β‐catenin conditional knockout (KO) mice and their wild‐type (WT) littermates to Fas and tumor necrosis factor‐α (TNF‐α), two common pathways of hepatocyte apoptosis.

A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice

Frank K. Huynh, Ursula H. Neumann, Ying Wang, Brian Rodrigues, Timothy J. Kieffer, Scott D. Covey – 3 September 2012 – Obesity is highly associated with dyslipidemia and cardiovascular disease. However, the mechanism behind this association is not completely understood. The hormone leptin may be a molecular link between obesity and dysregulation of lipid metabolism. Leptin can affect lipid metabolism independent of its well‐known effects on food intake and energy expenditure, but exactly how this occurs is ill‐defined.

Subscribe to